United States
Germany
Japan
United Kingdom
China
FCGR2A (CD32) mouse monoclonal antibody, clone OTI9C6 (formerly 9C6)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
Antibodies
FCGR2A (CD32) mouse monoclonal antibody, clone OTI13D7 (formerly 13D7)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI9G5 (formerly 9G5)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI16D6 (formerly 16D6)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI19C10 (formerly 19C10)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI13D7 (formerly 13D7)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI9C6 (formerly 9C6)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI6D11 (formerly 6D11)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI9G5 (formerly 9G5)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI15G5 (formerly 15G5)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI6H7 (formerly 6H7)
| Applications | IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI19C10 (formerly 19C10)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI16D6 (formerly 16D6)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI6D11 (formerly 6D11)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
FCGR2A (CD32) mouse monoclonal antibody, clone OTI15G5 (formerly 15G5)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
